ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100

October 4, 2022 | Comments Off on ER Stress Response and Induction of Apoptosis in Malignant Pleural Mesothelioma: The Achilles Heel Targeted by the Anticancer Ruthenium Drug BOLD-100

Cancers 2022 August 26 [Link] Elia Ranzato, Gregorio Bonsignore, Simona Martinotti Abstract Malignant mesothelioma is a rare cancer arising from the serosal surfaces of the body, mainly from the pleural…

Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin

October 3, 2022 | Comments Off on Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin

Cancers 2022 September 1 [Link] Michel Adamina, Maxime Warlaumont, Martin D Berger, Silvio Däster, Raphaël Delaloye, Antonia Digklia, Beat Gloor, Ralph Fritsch, Dieter Koeberle, Thibaud Koessler, Kuno Lehmann, Phaedra Müller,…

KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player

September 30, 2022 | Comments Off on KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player

Cancers 2022 September 2 [Link] Lilith Trassl, Georgios T Stathopoulos Abstract Malignant pleural mesothelioma (MPM) is a rare, incurable cancer of the mesothelial cells lining the lungs and the chest…

Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma

September 29, 2022 | Comments Off on Proposal for a new local recurrence score in patients with recurrent malignant pleural mesothelioma

Journal of Thoracic Disease 2022 August [Link] Olivia Lauk, Thomas Neuer, Bianca Battilana, Ilhan Inci, Katarzyna Furrer, Walter Weder, Masaki Hashimoto, Isabelle Opitz Abstract Background: Malignant pleural mesothelioma (MPM) is…

Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma

September 28, 2022 | Comments Off on Brief Report: Multimodality Therapy in Patients with Primary Pericardial Mesothelioma

Journal of Thoracic Oncology 2022 September 5 [Link] Michael Offin, Dilanka De Silva, Jennifer L Sauter, Jacklynn V Egger, Ellen Yorke, Prasad S Adusumilli, Andreas Rimner, Valerie W Rusch, Marjorie…

Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

September 27, 2022 | Comments Off on Survival Effect of Complete Multimodal Therapy in Malignant Pleural Mesothelioma

Journal of Chest Surgery 2022 September 7 [Link] Muhammet Sayan, Aynur Bas, Merve Satir Turk, Dilvin Ozkan, Ali Celik, İsmail Cuneyt Kurul, Abdullah Irfan Tastepe Abstract Background: Malignant pleural mesothelioma…

Meta-analysis of survival after extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) for malignant pleural mesothelioma in the context of macroscopic complete resection (MCR)

September 26, 2022 | Comments Off on Meta-analysis of survival after extrapleural pneumonectomy (EPP) versus pleurectomy/decortication (P/D) for malignant pleural mesothelioma in the context of macroscopic complete resection (MCR)

Updates in Surgery 2022 September 3 [Link] Dimitrios E Magouliotis, Prokopis-Andreas Zotos, Arian Arjomandi Rad, Despoina Koukousaki, Vasiliki Vasilaki, Ioustini Portesi, Kyriakos Spiliopoulos, Thanos Athanasiou Abstract Objective: We reviewed the…

A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) – a randomised feasibility study using the trial within a cohort (TwiC) methodology

September 23, 2022 | Comments Off on A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) – a randomised feasibility study using the trial within a cohort (TwiC) methodology

Pilot & Feasibility Studies 2022 September 3 [Link] Anna C Bibby, Natalie Zahan-Evans, Emma Keenan, Charles Comins, John E Harvey, Helen Day, Najib M Rahman, Janet E Fallon, Rachael Gooberman-Hill,…

Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience

September 22, 2022 | Comments Off on Feasibility and safety of extended pleurectomy/decortication for malignant pleural mesothelioma. A single group experience

Thoracic Cancer 2022 September 2 [Link] Francesco Falanga, Pietro Rinaldi, Cristiano Primiceri, Chandra Bortolotto, Olga Oneta, Francesco Agustoni, Patrizia Morbini, Laura Saracino, Dimitrios Eleftheriou, Federico Sottotetti, Giulia Maria Stella Abstract…

IL-7 is expressed in malignant mesothelioma and has a prognostic value

September 21, 2022 | Comments Off on IL-7 is expressed in malignant mesothelioma and has a prognostic value

Molecular Oncology 2022 August 28 [Link] Hoa-Le Mai, Sophie Deshayes, Thi-Van-Ha Nguyen, Virginie Dehame, Anne-Laure Chéné, Sophie Brouard, Christophe Blanquart Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer mainly…

Categories